April 1, 2014

Prasco Labs on Tuesday announced that it has signed a marketing and distribution agreement with Eli Lilly and Co. to market the authorized generic version of Evista (raloxifene hydrochloride tablets), 60 mg strength, in the United States.

November 14, 2012

The Community Specialty Pharmacy Network has entered a contract with Dara BioSciences to distribute a nonsteroidal anti-estrogen product.

October 7, 2011

A popular breast cancer treatment may pose an increased risk of diabetes among older women, according to a new study.

May 6, 2011

Greenstone has introduced an authorized generic treatment for breast cancer, the generics subsidiary of Pfizer said.

September 26, 2010

Supermarket chain Stater Bros. is marking National Breast Cancer Awareness Month in October by giving...

May 5, 2010

Watson Pharmaceuticals is challenging the patent covering a drug for postmenopausal women, the generic drug...